10-Q Filing

AGIOS PHARMACEUTICALS, INC. CIK: 1439222 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0001439222-22-000040`
Period End Date	20220331
Filing Date	20220505
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	agio-20220331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 40 Cash Flow Statement 72 Stockholders Equity 18 Comprehensive Income 6

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$80.03M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$203.13M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$816.89M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$843.50M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable, net	`ContractWithCustomerAssetNetCurrent`	-	USD	Point-in-time
Accounts receivable, net	`ContractWithCustomerAssetNetCurrent`	$540.00K	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$4.38M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$5.37M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Inventory	`InventoryNet`	$2.48M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	70.55M	shares	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	70.99M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	54.33M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	54.78M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$39.84M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$43.23M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.06B	USD	Point-in-time
Treasury stock, shares (in shares)	`TreasuryStockShares`	16.22M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$975.14M	USD	Point-in-time
Treasury stock, shares (in shares)	`TreasuryStockShares`	16.22M	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$266.38M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$255.84M	USD	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$75.12M	USD	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$72.69M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$28.92M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$29.20M	USD	Point-in-time
Financing lease assets	`FinanceLeaseRightOfUseAsset`	$95.00K	USD	Point-in-time
Financing lease assets	`FinanceLeaseRightOfUseAsset`	$183.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$2.90M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$2.90M	USD	Point-in-time
Total assets	`Assets`	$1.44B	USD	Point-in-time
Total assets	`Assets`	$1.34B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$16.70M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$11.55M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$31.97M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$19.75M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$10.83M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$11.74M	USD	Point-in-time
Financing lease liabilities	`FinanceLeaseLiabilityCurrent`	$250.00K	USD	Point-in-time
Financing lease liabilities	`FinanceLeaseLiabilityCurrent`	$331.00K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	-	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$2.50M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$45.79M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$59.83M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$85.66M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$82.34M	USD	Point-in-time
Financing lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$276.00K	USD	Point-in-time
Financing lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$276.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$128.41M	USD	Point-in-time
Total liabilities	`Liabilities`	$145.76M	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at March 31, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at March 31, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 70,993,277 shares issued and 54,776,467 shares outstanding at March 31, 2022, and 70,550,631 shares issued and 54,334,220 shares outstanding at December 31, 2021	`CommonStockValue`	$71.00K	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 70,993,277 shares issued and 54,776,467 shares outstanding at March 31, 2022, and 70,550,631 shares issued and 54,334,220 shares outstanding at December 31, 2021	`CommonStockValue`	$71.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.33B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.35B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-7.75M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-1.20M	USD	Point-in-time
Treasury stock, at cost (16,216,411 shares at March 31, 2022 and December 31, 2021)	`TreasuryStockValue`	$802.49M	USD	Point-in-time
Treasury stock, at cost (16,216,411 shares at March 31, 2022 and December 31, 2021)	`TreasuryStockValue`	$802.49M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-333.53M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-238.76M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.21B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$2.30B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.29B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$399.50M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.44B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.34B	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$832.00K	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	-	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$339.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$57.67M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$70.12M	USD	1 Quarter
Selling, general and administrative	`GeneralAndAdministrativeExpense`	$31.52M	USD	1 Quarter
Selling, general and administrative	`GeneralAndAdministrativeExpense`	$33.55M	USD	1 Quarter
Total cost and expenses	`CostsAndExpenses`	$101.98M	USD	1 Quarter
Total cost and expenses	`CostsAndExpenses`	$91.22M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-91.22M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-101.14M	USD	1 Quarter
Royalty income from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Royalty income from gain on sale of oncology business	`GainLossOnSaleOfBusiness`	$2.70M	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$340.00K	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$694.00K	USD	1 Quarter
Other income, net	`OtherOperatingIncomeExpenseNet`	$2.97M	USD	1 Quarter
Other income, net	`OtherOperatingIncomeExpenseNet`	-	USD	1 Quarter
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-94.77M	USD	1 Quarter
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-90.88M	USD	1 Quarter
Net income from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$1.97B	USD	1 Quarter
Net income from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	-	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-94.77M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$1.87B	USD	1 Quarter
Net loss from continuing operations per share - basic (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.74	USD	1 Quarter
Net loss from continuing operations per share - basic (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.31	USD	1 Quarter
Net loss from continuing operations per share - diluted (in usd per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-1.31	USD	1 Quarter
Net loss from continuing operations per share - diluted (in usd per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-1.74	USD	1 Quarter
Net income from discontinued operations per share - basic (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$28.26	USD	1 Quarter
Net income from discontinued operations per share - basic (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	1 Quarter
Net income from discontinued operations per share - diluted (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$28.26	USD	1 Quarter
Net income from discontinued operations per share - diluted (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Net (loss) income per share - basic (in usd per share)	`EarningsPerShareBasic`	$-1.74	USD	1 Quarter
Net (loss) income per share - basic (in usd per share)	`EarningsPerShareBasic`	$26.95	USD	1 Quarter
Net (loss) income per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-1.74	USD	1 Quarter
Net (loss) income per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$26.95	USD	1 Quarter
Weighted-average number of common shares used in computing net loss per share from continuing operations, net income from discontinued operations and net (loss) income per share - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	69.54M	shares	1 Quarter
Weighted-average number of common shares used in computing net loss per share from continuing operations, net income from discontinued operations and net (loss) income per share - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	54.56M	shares	1 Quarter
Weighted-average number of common shares used in computing net loss per share from continuing operations, net income from discontinued operations and net (loss) income per share - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	54.56M	shares	1 Quarter
Weighted-average number of common shares used in computing net loss per share from continuing operations, net income from discontinued operations and net (loss) income per share - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	69.54M	shares	1 Quarter

Cash Flow Statement 72 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`NetIncomeLoss`	$-94.77M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$1.87B	USD	1 Quarter
Less: Net income from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$1.97B	USD	1 Quarter
Less: Net income from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	-	USD	1 Quarter
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-94.77M	USD	1 Quarter
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-90.88M	USD	1 Quarter
Depreciation and amortization	`OtherDepreciationAndAmortization`	$2.48M	USD	1 Quarter
Depreciation and amortization	`OtherDepreciationAndAmortization`	$2.48M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$14.85M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$15.51M	USD	1 Quarter
Net amortization of premium (accretion of discount) on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.15M	USD	1 Quarter
Net amortization of premium (accretion of discount) on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.66M	USD	1 Quarter
Non-cash operating lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$2.42M	USD	1 Quarter
Non-cash operating lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$2.44M	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInContractWithCustomerAsset`	$540.00K	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInContractWithCustomerAsset`	-	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$2.48M	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	-	USD	1 Quarter
Other receivables	`IncreaseDecreaseInOtherReceivables`	$987.00K	USD	1 Quarter
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	1 Quarter
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.39M	USD	1 Quarter
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.62M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.94M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-5.01M	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-12.22M	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-12.70M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	-	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$2.50M	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.50M	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-2.40M	USD	1 Quarter
Net cash used in operating activities - continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-90.23M	USD	1 Quarter
Net cash used in operating activities - continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-97.73M	USD	1 Quarter
Net cash used in operating activities - discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	-	USD	1 Quarter
Net cash used in operating activities - discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-30.52M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-120.75M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-97.73M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$355.92M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$61.86M	USD	1 Quarter
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$332.15M	USD	1 Quarter
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$134.02M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.01M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.80M	USD	1 Quarter
Net cash (used in) provided by investing activities - continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$71.14M	USD	1 Quarter
Net cash (used in) provided by investing activities - continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-26.57M	USD	1 Quarter
Net cash provided by investing activities - discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$1.80B	USD	1 Quarter
Net cash provided by investing activities - discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	1 Quarter
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-26.57M	USD	1 Quarter
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.87B	USD	1 Quarter
Payments on financing lease obligations	`FinanceLeasePrincipalPayments`	$81.00K	USD	1 Quarter
Payments on financing lease obligations	`FinanceLeasePrincipalPayments`	$86.00K	USD	1 Quarter
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$7.35M	USD	1 Quarter
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$1.29M	USD	1 Quarter
Net cash provided by financing activities - continuing operations	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.21M	USD	1 Quarter
Net cash provided by financing activities - continuing operations	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$7.26M	USD	1 Quarter
Net cash provided by financing activities - discontinued operations	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	1 Quarter
Net cash provided by financing activities - discontinued operations	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.21M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$7.26M	USD	1 Quarter
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.76B	USD	1 Quarter
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-123.10M	USD	1 Quarter
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.89B	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$127.44M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$203.13M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$80.03M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.89B	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$127.44M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$203.13M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$80.03M	USD	Point-in-time
Additions to property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$1.54M	USD	1 Quarter
Additions to property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$6.00K	USD	1 Quarter
Cash taxes paid	`IncomeTaxesPaidNet`	-	USD	1 Quarter
Cash taxes paid	`IncomeTaxesPaidNet`	$1.84M	USD	1 Quarter

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$1.21B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$2.30B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.29B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$399.50M	USD	Point-in-time
Common stock issued under stock incentive plan and ESPP (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	3,250.00	shares	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.29M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$7.35M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$15.51M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.85M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-108.00K	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-6.55M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-94.77M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$1.87B	USD	1 Quarter
Disposition of oncology business	`StockholdersEquityDispositionOfBusiness`	$-712.00K	USD	1 Quarter
Ending balance	`StockholdersEquity`	$1.21B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$2.30B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.29B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$399.50M	USD	Point-in-time

Comprehensive Income 6 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`NetIncomeLoss`	$-94.77M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$1.87B	USD	1 Quarter
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-108.00K	USD	1 Quarter
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-6.55M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$-101.32M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$1.87B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.